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Edited by Vladimir SkulachevAbstract Hypoxia-inducible factor (HIF) is a transcriptional
complex that is regulated by oxygen sensitive hydroxylation of
its a subunits by the prolyl hydroxylases PHD1, 2 and 3. To
better understand the role of these enzymes in directing cellular
responses to hypoxia, we derived an assay to determine their
speciﬁc activity in both native cell extracts and recombinant
sources of enzyme. We show that all three are capable of high
rates of catalysis, in the order PHD2¼PHD3 > PHD1, using
substrate peptides derived from the C-terminal degradation
domain of HIF-a subunits, and that each demonstrates similar
and remarkable sensitivity to oxygen, commensurate with a
common role in signaling hypoxia.
 2004 Federation of European Biochemical Societies. Published
by Elsevier B.V. All rights reserved.
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Hypoxia-inducible factor (HIF), comprising a heterodimer
of a and b subunits [1], is a central mediator of many tran-
scriptional adaptations to hypoxia. The a subunit is rapidly
degraded in the presence of oxygen, leading to inactivation of
the hypoxic response [2]. In normoxia HIF-a binds the von
Hippel–Lindau tumor suppressor protein (pVHL), which
forms the recognition component of an E3 ubiquitin ligase
complex, leading to ubiquitylation of HIF-a and consequent
degradation by the ubiquitin-proteasome pathway [3,4]. The
targeting event is an oxygen dependent enzymatic hydroxyl-
ation of speciﬁc prolyl residues [5–7], which uses 2-oxoglu-
tarate as a co-substrate. Analysis of HIF-prolyl hydroxylase
activity is therefore an important focus for understanding how
cells respond to hypoxia.* Corresponding author. Fax: +44-1865-287533.
E-mail address: drmole@well.ox.ac.uk (D.R. Mole).
Abbreviations: HIF, hypoxia-inducible factor; PHD, prolyl hydroxy-
lase domain containing protein; pVHL, von Hippel–Lindau tumor
suppressor protein; IVTT, in vitro transcription/translation; BT19, N-
terminal biotinylated 190mer peptide (HIF-1a 556–574); BT19OH,
BT19 with proline 564 substituted by hydroxyproline; siRNA, small
interfering RNA; RNAi, RNA interference.
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doi:10.1016/j.febslet.2004.09.005Following identiﬁcation of cDNAs encoding three human
HIF-prolyl hydroxylases, termed PHD (prolyl hydroxylase
domain) 1–3 [8], recombinant enzyme preparations produced
in bacteria were shown to hydroxylate HIF peptides in vitro,
but observed rates of catalysis were low (approximately
7 103 mol/mol/min) [9]. More recently, recombinant PHD
from insect cells has been used in kinetic analyses using the rate
of [14C]CO2 released on decarboxylation of [1-
14C]a-ketoglu-
tarate, to measure enzyme activity [9,10]. These studies pro-
vided data on a number of important kinetic parameters, and
indicated that the catalytic rate is most probably much higher
than that estimated above, but did not measure enzyme con-
centration, and therefore could not provide measurements of
speciﬁcity activity.
To understand HIF-prolyl hydroxylation better, we derived
an assay that could measure the speciﬁc activity of HIF-prolyl
hydroxylases and could be applied to small quantities of un-
puriﬁed enzyme in biological samples. Since [1-14C]a-ketoglu-
tarate decarboxylation assays use large amounts of enzyme and
require puriﬁed or overexpressed enzyme to obviate back-
ground release of [14C]CO2 by other pathways, they are not
suitable for assaying activity in samples such as crude cell ex-
tracts. In another type of assay, pVHL capture has been used to
detect the production of hydroxylated HIF-a through the
speciﬁc interaction of pVHL with hydroxylated but not un-
modiﬁed peptide. However, though sensitive and speciﬁc, such
assays have not, to date, been used in a quantitative format.
Here we show, using a synthetic hydroxylated HIF-1a pep-
tide for calibration and methods for enzyme quantiﬁcation,
that the pVHL capture assay provides a method for mea-
surement of speciﬁc activity with suﬃcient sensitivity to mea-
sure PHD activity in crude cell extracts. We report the use of
this assay to measure the speciﬁc activity of endogenous HIF-
prolyl hydroxylase in mammalian cell extracts, to compare the
speciﬁc activities of diﬀerent PHD isoforms and their response
to hypoxia, and to compare the activity of diﬀerent re-
combinant enzyme preparations.2. Materials and methods
2.1. Cell Culture and preparation of endogenous PHD2
HEK293T and MDA-MB-435 cells were cultured at 37 C in Dul-
becco’s modiﬁed Eagle’s medium (DMEM) with 10% fetal bovine se-
rum. Sf9 cells, were maintained in Sf-900 II serum-free medium (Life
Technologies) at 27 C. Endogenous PHD2 was prepared byblished by Elsevier B.V. All rights reserved.
Fig. 1. (A) and (B) Calibration of captured pVHL against amount of
hydroxylated peptide. Known amounts of BT19OH were added to a
ﬁxed quantity of BT19, before binding to streptavidin coated beads,
and [35S]pVHL capture. Following SDS–PAGE, [35S]pVHL was
quantiﬁed by autoradiography using a phosphorimager and calibrated
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by sonication into 150 mM sodium chloride, 20 mM Tris (pH 7.5) and
1 mM dithiothreitol.
2.2. RNA interference
MDA-MB-435 cells were transfected at 0 and 24 h with PHD2 speciﬁc
small interfering RNA (siRNA) (corresponding to nucleotides 4077–
4097) [11], using Oligofectamine (Ambion), and extracts prepared 24 h
later, as above.Eﬃcacyand speciﬁcityofRNAinterference (RNAi)were
conﬁrmed by immunoblotting for PHD1, PHD2 and PHD3 (see below).
2.3. In vitro transcription/translation
[35S]Methionine labeled proteins were synthesized by in vitro tran-
scription/translation (IVTT) reactions using TNT T7 Quick Coupled
Rabbit Reticulocyte Lysate (Promega). Plasmids encoding each PHD
in pcDNA3 (Invitrogen) have been described previously [8].
2.4. Expression and puriﬁcation of recombinant PHD enzymes from Sf9
cells
Recombinant baculoviruses containing genes encoding the N-
terminal FLAG-tagged and untagged PHD1, 2, and 3 were prepared
using the Bac-to-Bac (Life Technologies) or Sapphire (Orbigen) bac-
ulovirus expression systems. FLAG-tagged PHD2 was prepared by
sonicating Sf9 cells, 70 h post-infection, into 50 mM Tris, pH 7.4, 150
mM NaCl, 0.1% Triton X-100, and Complete Protease Inhibitors
(Roche). The soluble fraction was applied to an anti-FLAG M2 af-
ﬁnity column (Sigma) and eluted using FLAG octapeptide (Sigma).
Crude extracts of Sf9 cells expressing untagged PHD2 were harvested
as for MDA-MB-435 cells.
2.5. Expression of recombinant PHD2 enzyme in HEK293T cells
HEK293T cells were transfected with pcDNA3 PHD2 expression
vector [8], using polyethyleneimine. Cells were harvested 48 h post-
transfection and extracts prepared as for MDA-MB-435 cells.
2.6. Antibodies and immunoblotting
Mouse monoclonal antibody to PHD2 [11] was used in immunoblots
to quantify PHD2 in extracts, by comparison with puriﬁed FLAG-
tagged PHD2. Relative concentrations of each PHD in MDA-MB-435
extract were determined, by comparison with equal molar amounts of
PHD (as judged by [35S]methionine incorporation) produced in IVTT
reactions, using rabbit polyclonal antibodies to PHD1 and PHD2, and
mouse monoclonal antibody to PHD3 [11].
2.7. Biotinylated peptides
N-terminal biotinylated peptides corresponding to HIF-1a residues
556–574 (biotin-DLDLEMLAPYIPMDDDFQL)(BT19), HIF-2a
(biotin-ELDLETLAPYIPMDGEDFQL) and HIF-3a (biotin-ALD-
LEMLAPYISMDDDFQL) were used (Peptide Protein Research Ltd).
The equivalent HIF-1a peptide with Pro564 substituted by hydroxy-
proline (BT19OH) was used to calibrate the assay.
2.8. Enzyme assays
Biotinylated synthetic HIF-a peptides (1 lM) were incubated, at 37
C, in a reactionmix containing the enzyme, 50 mMTris (pH 7.5), 2 mg/
ml BSA, 1 mM DTT, 1 mM a-ketoglutarate, 1 mM ascorbate, 50 lM
FeCl2, and 0.3 mg/ml catalase. Reactions were commenced by addition
of the enzyme. Aliquots were removed at various time points and further
reaction stopped by dilution in ice-cold ‘stop buﬀer’ (150 mMNaCl, 20
mM Tris (pH 7.5) and 0.5% Igepal, 300 lM desferrioxamine mesylate
(DFO)). The biotinylated peptide was captured using streptavidin-
conjugated magnetic beads in ‘capture buﬀer’ (150 mM NaCl, 20 mM
Tris (pH 7.5), 0.5% Igepal and 100 lMDFO) followed by washing. The
peptide-coated beads were then incubated at 4 Cwith excess [35S]pVHL
produced by IVTT reaction, diluted in ‘‘capture buﬀer’’. Following two
further washes, captured [35S]pVHLwas quantiﬁed by SDS–PAGE and
autoradiography using a phosphorimager.against the amount of hydroxylated peptide. (C) Quantiﬁcation of
PHD enzymes. The amount of reticulocyte IVTT PHD2 was quanti-
ﬁed against known amounts of puriﬁed FLAG-PHD2, by comparative
immunoblot. (D) Purity of the FLAG-PHD2 is demonstrated. (E) and
(F) The concentrations of IVTT PHD1 and 3 were quantiﬁed by
comparison with IVTT PHD2 using autoradiography and phosphor-
imaging of [35S]PHD IVTTs, making allowance for relative methionine
content.3. Results and discussion
3.1. Design of quantitative pVHL capture assay
The pVHL capture method reports hydroxyproline content
based on the highly speciﬁc and well characterized interactionbetween pVHL and HIF-1a hydroxylated at position Pro564
[5,8,12,13]. A minimal HIF-1a peptide (residues 556–574) was
used, since previous studies have established that, for this
hydroxylation site, binding aﬃnities to pVHL [13] and
PHD enzyme kinetics [10] are unaﬀected by the use of longer
peptides.
Calibration of peptide hydroxylation was performed by
mixing known amounts of biotinylated synthetic peptide,
containing hydroxyproline, with non-hydroxylated peptide, in
capture buﬀer. This allowed the signal obtained from captured
[35S]pVHL to be calibrated against the amount of hydroxyl-
ated peptide present (Fig. 1A and B). Background binding to
non-hydroxylated peptide was undetectable. The calibration
curves demonstrated good linearity and, in all reactions, the
proportion of peptide hydroxylated was low, such that ob-
served rates approximated initial reaction rates.
PHD2 concentration in lysates was determined using known
quantities of FLAG-PHD2, puriﬁed to homogeneity from Sf9
cells, to calibrate immunoblot signals obtained using mono-
clonal antibodies against PHD2 (Fig. 1C). The N-terminal
FLAG tag did not aﬀect antigenicity (data not shown). Purity
was veriﬁed by SDS–PAGE (Fig. 1D) and protein concentration
Fig. 2. Determination of endogenous PHD2 activity in hypoxically
incubated MDA-MB-435 cell extracts. (A) Immunoblots comparing
equivalent amounts of PHD IVTTs with hypoxic MDA435 extract
demonstrate that PHD2 is the dominant isoform expressed. (B) PHD2
from MDA435 extract was quantiﬁed by comparative immunoblot
with puriﬁed FLAG-PHD2. (C) Enzyme assays were performed on
MDA-MB-435 extract. Means and standard deviations are for three
independent experiments. (D) PHD1, PHD2 and PHD3 immunoblots
demonstrate (6–8-fold) suppression of PHD2 in MDA-MB-435 cells
by RNAi, but no eﬀect on PHD1. (E) Suppression of PHD2 by RNAi
results in loss of activity in pVHL capture assay.
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absolute concentration of PHD2 was calculated.
Initial work to produce puriﬁed recombinant PHD enzymes
using a baculoviral expression system had revealed that PHD3
was almost entirely insoluble when expressed in the Sf9 cells
and that PHD1 was only marginally soluble. Therefore, stan-
dard preparations for calibrating anti-PHD1 and anti-PHD3
signals on immunoblots could not be obtained. However, by
incorporating a [35S]methionine radiolabel in IVTT prepara-
tions, the relative amounts of each PHD isoform could be
measured, and hence, by comparison with PHD2, the absolute
concentration of each determined (Fig. 1E and F).
The method of detection is extremely sensitive allowing the
activity of very small quantities of enzyme to be determined
(currently 4–10 fmol of enzyme in a volume of 10–25 ll).
Furthermore, assaying peptide hydroxylation permits deter-
mination of PHD activity in crude cell lysates, without the
confounding issue of non-PHD related a-ketoglutarate turn-
over. This obviates the need for puriﬁcation of soluble enzyme,
where eﬀects on activity may be substantial [10] (and personal
observation).
3.2. Measurement of the speciﬁc activity of endogenous and
recombinant PHD enzymes
Endogenous PHD2 activity. Circumstances under which either
PHD1 or PHD3 are expressed in isolation have not been
determined [11]. We therefore sought to determine endogenous
PHD2 activity, in order to provide a comparison for prepara-
tions of recombinant enzyme. Analysis was performed on
extracts prepared from hypoxic MDA-MB-435 cells. Immuno-
blotting experiments, comparing this extract with equal molar
quantities of each [35S]methionine labeled PHD, produced in
reticulocyte lysate IVTT reactions, indicate that under these
circumstances PHD2 accounts for >95% total PHD immuno-
activity (Fig. 2A), comparable with published results [11]. Cell
extracts prepared from hypoxic MDA-MB-435 cells were
estimated to contain approximately 4nMPHD2by comparative
immunoblotting (Fig. 2B).
Enzyme assays were performed in triplicate using these
extracts (Fig. 2C). The initial reaction was linear over a 6-
min period and yielded a value for speciﬁc activity of ap-
proximately 20 mol/mol/min. This result is much greater
than that reported for puriﬁed PHD1 (7 103 mol/mol/
min) [9], although lower than for FIH (85–135 mol/mol/min)
[14] or collagen prolyl 4-hydroxylase (400 mol/mol/min) [15].
The value represents a lower limit for Vmax as the concen-
tration of peptide used in the assays (1 lM) was below the
reported Km (7 lM) [10]. However, when the peptide con-
centration was increased above 1 lM a paradoxical fall in
speciﬁc activity was recorded. Reduction in peptide con-
centration to 0.05 lM resulted in a proportionate fall in
turnover consistent with these concentrations being below
the Km.
Finally, to further conﬁrm that the measured activity was
due to PHD2, its level was suppressed by RNAi (Fig. 2D).
This abrogated pVHL capture in the assay (Fig. 2E) to a
level commensurate with the reduction in PHD2 immuno-
reactivity, indicating that it is the predominant PHD activity
in this extract.
Activity of recombinant PHD enzymes. Next, PHD2 activity
from diﬀerent eukaryotic expression systems, that expressed
largely soluble enzyme, was compared. Since preliminary ex-periments indicated that both addition of an aﬃnity tag and
puriﬁcation procedures altered enzyme activity, measurements
were performed on unpuriﬁed preparations of untagged en-
zyme. All extracts were diluted to comparable PHD2 concen-
trations, in extract buﬀer containing 2 mg/ml BSA and known
co-factors, prior to assay, to avoid saturating the assay. Ac-
tivity of recombinant PHD2 prepared in a reticulocyte IVTT
system, HEK293T mammalian cells, and Sf9 insect cells was
compared with that of native PHD2 from hypoxic MDA-MB-
435 cells. All preparations were catalytically active (Fig. 3).
Fig. 3. Comparison of PHD2 from diﬀerent sources. Enzyme assays
were performed using reticulocyte IVTT PHD2, and identically pre-
pared crude cell lysates of hypoxic MDA-MB-435 cells, transiently
transfected HEK293T cells, and baculovirus infected Sf9 cells (+).
Unprogrammed reticulocyte lysate IVTT, untransfected HEK293T
cells, and uninfected Sf9 cells ()) were used to determine baseline ac-
tivity for each source. All lysates were diluted to comparable PHD2
concentrations prior to assay. (A) Comparative immunoblot. (B) Ini-
tial reaction rates.
Fig. 4. Comparison of PHD isoforms. (A) Enzyme assays were per-
formed, using HIF-1a BT19 substrate and [35S]PHD1, 2, and 3 pro-
duced in rabbit reticulocyte lysate IVTTs, with unprogrammed lysate
determining baseline. [35S]pVHL capture was normalized for the rel-
ative amount of each PHD. (B) and (C) The experiment was repeated
using HIF-2a and HIF-3a peptides.
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IVTT preparation was comparable to that of native PHD2 in
MDA-MB-435 extracts (approximately 20 mol/mol/min),
somewhat lower speciﬁc activity was observed in preparations
from HEK293T cells and Sf9 cells. Both these systems ex-
pressed PHD2 at very high levels and it is possible that re-
duction in activity is due to a non-speciﬁc eﬀect of dilution or
dilution of a speciﬁc component required for activity. Similar
reductions in activity with mammalian and insect cell prepa-
ration mitigate against a failure of a species speciﬁc post-
translational modiﬁcation causing the eﬀect. In keeping with
this, further experiments showed that PHD2, expressed in
wheat germ IVTT, had comparable activity to that produced
in the reticulocyte system (not shown).
Comparison of activity of PHD1, 2, and 3. Since PHD2
produced in reticulocyte IVTT had comparable activity to
native protein, and testing of other expression systems had
revealed solubility problems with PHD1and PHD3, we fo-
cused on the reticulocyte system for comparative studies. Each
PHD isoform was produced identically in the IVTT system.
[35S]methionine labeling was used to normalize molar equiva-
lent enzyme quantities. Full solubility of each isoform, in the
reaction mix, was conﬁrmed by autoradiography before and
after centrifugation. Results using the 19-residue (556–574)
HIF-1a peptide as substrate are shown (Fig. 4A) and reveal
very similar speciﬁc activities for PHD2 and PHD3, and sub-
stantially lower activity for PHD1.Further experiments were performed using the equivalent 19
residue peptides from HIF-2a and HIF-3a (Fig. 4B and C).
Very similar relative activities in the order PHD2¼
PHD3 > PHD1 were observed for all peptides, though since
calibrating hydroxylated peptides were not used for the HIF-
2a and HIF-3a based assays, the ﬁgures are relative, rather
than absolute, measures of activity.
3.3. Oxygen dependence of PHD activity
Reticulocyte IVTT preparations of the PHD enzymes were
next used to compare the dependence of activity on oxygen
concentration for each isoform. In these experiments, both the
reaction mix and enzyme preparation were pre-equilibrated at
the designated ambient oxygen concentration in an Invivo2
Hypoxia Workstation (Ruskinn/Biotrace International) prior
to commencing the reaction. Results are shown (Fig. 5) and
Fig. 5. Oxygen dependence of PHD isoforms. (A), (B) and (C) Enzyme
assays were performed, using HIF-1a, for each PHD isoform, after
pre-equilibration across a range of ambient oxygen concentrations.
[35S]pVHL capture is expressed as percent maximal capture.
J.R. Tuckerman et al. / FEBS Letters 576 (2004) 145–150 149reveal similar oxygen dependence for the activity of each PHD
isoform. In each case, the reaction rate was oxygen dependent
over the full range of concentrations used, from 1% to 21%
oxygen, with no indication of saturation.
Our data complement recent comparative studies of the
PHD enzymes conducted both in vitro and in vivo. Hirsila
et al. [10] studied the kinetics of recombinant PHD enzymes in
unpuriﬁed insect cell lysates, deriving Km values for substrates
and co-factors. Of particular interest, in these [1-14C]a-keto-
glutarate decarboxylation assays, each PHD isoform manifests
unusual sensitivity to hypoxia, with very high Km values (230–
250 lM). The current work, using quantitative VHL capture
assays, shows no evidence of saturation under ambient oxygen
concentrations up to 21%. Assuming oxygen solubility at 37 C
of 1.30 lmol/l/mmHg [16], this is equivalent to a concentration
of roughly 200 lM. These values are signiﬁcantly in excess of
tissue pO2. Thus, two diﬀerent types of assays reveal that PHDenzyme activity is oxygen concentration dependent over the
entire physiological range, consistent with a role in regulating
homeostatic responses to oxygen.
Our data indicate that all PHD enzymes are capable of
acting catalytically to generate many molecules of hydroxyl-
ated HIF-a for each PHD molecule, and give a speciﬁc activity
of approximately 20 mol/mol/min for PHD2 and PHD3 and
somewhat lower for PHD1. These values provide only a lower
limit for Vmax, since the concentrations of HIF peptide and
oxygen used were less than the reported Km for this substrate.
Superﬁcially, this might suggest that cells possess an excess
capacity for HIF hydroxylation that could not be rate limiting
in HIF regulation. However, the HIF peptide concentrations
used in these assays (1 lM) remain greatly in excess of the
concentration of HIF-a in cells (estimated to be in the sub-
nanomolar range). Assuming an approximately linear reduc-
tion in catalytic rate with substrate concentration, capacity for
hydroxylation of native HIF-a subunits would be much lower,
potentially compatible with a regulatory function.
The importance of PHD2 function in the regulation of
normoxic HIF level has recently been demonstrated in vivo by
suppression of PHD expression by siRNA [17]. However, an-
other study has demonstrated that when expressed at compa-
rable levels, PHD1 and PHD3 could also inﬂuence the level of
HIF-1a consistent with our data. It is likely that, in vivo, many
other factors (particularly the relative abundance of the en-
zymes in cells under analysis) will contribute to the observed
eﬀect of suppression by siRNA. Our results are however
somewhat diﬀerent from those reported by Huang et al. [18],
which gave relative activities in the order PHD2 > PHD3 >
PHD1, using an uncalibrated VHL capture assay and nickel
aﬃnity chromatography puriﬁed, tagged recombinant PHDs
expressed in insect cells. Lower activity for PHD3 in the latter
system might result from tagging and puriﬁcation. Alterna-
tively, recent work has identiﬁed the chaperone complex TRiC
as a PHD3 binding complex [19], and this association may
be required for production of fully active enzyme in some
circumstances.
Overall, our data showing high levels of HIF-hydroxylase
activity and striking oxygen sensitivity for the three PHD
isoforms support a role for each in the oxygen dependent
regulation of HIF. The calibrated VHL capture assay should
provide a means for analyzing the biological control of this
pathway in greater detail.Acknowledgements: We thank J. Gleadle for providing the PHD
cDNAs, and The Wellcome Trust and The Medical Research Council
for funding this research.References
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